Active	Status	Sponsor type	Region	Phase	Filter
2 Active 5 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
tecarfarin (ATI-5923) / Cadrenal Therapeutics
NCT04627116: An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers	Enrolling by invitation	1	40	RoW	Tecarfarin	Lee's Pharmaceutical Limited	Healthy Chinese Volunteers	12/20	12/20
budiodarone (ATI-2042) / Espero BioPharma
2004-002996-18: A Phase 2 Pilot Study of the Efficacy of ATI-2042 in subjects with Paroxysmal Atrial Fibrillation and Pacemakers	Ongoing	2	16	Europe	ATI-2042, NA,	ARYx Therapeutics Limited	Paroxysmal Atrial Fibrillation